SEC Tracker
Get the app

Dyne Therapeutics DYN

Brian S Posner (DYN) reports stock transaction.

Brian S Posner, insider filing for DYN

Form
4
Filed
Importance
Routine
  1. Brian S. Posner acquired 2,500 shares on Oct 2, 2026.
  2. Posner now holds 27,000 shares directly.
  3. Transaction type was purchase (P).
  4. Stock price was $16 per share.

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Dyne Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Akebia Therapeutics AKBA public float $946M, Jun 30, 2025
  2. Viridian Therapeutics VRDN public float $943M, Jun 30, 2025
  3. Collegium Pharmaceutical COLL public float $926M, Jun 30, 2025
  4. Neogen NEOG public float $972M, Nov 30, 2025
  5. Ardelyx ARDX public float $924M, Jun 30, 2025